1st Annual Walk to Remember James Francis Urian Esophageal Cancer Awareness In-person: Saturday, April 22, 2023, 9:00 AM Rocky Neck State Park in Niantic, CT Virtual: Saturday, April 22, 2023, or Sunday, April 23, 2023
Sign up coming soon!
Linda’s Trail of Love, 2nd Annual Esophageal Cancer 5K Run/Walk
In-person: Saturday, May 20, 2023, 9:00 AM Columbia Trail, Califon, NJ Virtual: Saturday, May 20, 2023 or Sunday, May 21, 2023
The Salgi Esophageal Cancer Research Foundation’s Grant Program is now open. Researchers are invited to apply for funding. The deadline to submit Letters of Intent is Thursday, February 2, 2023.
Then in 2018, The Salgi Esophageal Cancer Research Foundation awarded principal investigator, Dr. Donald Low and Virginia Mason Medical Center, grant funding. Dr. George Hanna of St Mary’s Hospital (Imperial College London) is co-investigator. The research intends to establish a non-invasive test for the detection of esophageal cancer that is based upon the unique signature of volatile organic compounds (VOCs) within exhaled breath and to analyze exhaled VOCs in response to therapeutic intervention in patients. This research is currently underway.
With over a 733% increase in the past four decades, esophageal cancer is among the fastest growing and deadliest cancers in the United States and the western world. There are no current standard or routine screenings to detect esophageal cancer in its earlier stages. Current guidelines recommend referral for endoscopy “only in the setting of ‘red flag’ symptoms that are frequently associated with inoperable disease,” Dr. Low stated.
These ‘red flag’ symptoms, such as difficulty swallowing, chronic cough, and GERD, typically appear once the cancer has become advanced. This, in addition with other factors, leads to the current overall five-year survival rate of only 20.6%. Despite its rapid increase and poor prognosis, esophageal cancer receives very little awareness and research funding.
Despite its rapid increase and poor prognosis, many people are still unaware of esophageal cancer and research is critically underfunded. “We are honored to once again open our Grant Program and look forward to awarding esophageal cancer research funding in 2023.”
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
During this season of holiday giving, we would like to take the time to express our sincere gratitude. Thanks to you, we have made tremendous achievements over the years.
Research. Esophageal cancer is considered one of the fastest growing and deadliest cancers in the United States, according to the National Cancer Institute. Esophageal cancer has increased over 700% in the past four decades. Despite this, esophageal cancer research receives very little private or government funding. The Salgi Esophageal Cancer Research Foundation awarded esophageal cancer research in 2015 and in 2018. In November 2022, we opened our grant program for the third time! We are working to fund more research in 2023.
Early Detection. In November 2018, we issued esophageal cancer research funding for the second time in less than seven years since our charity was founded. This research, a breath test to detect esophageal cancer, is currently underway at Virginia Mason. The research intends to establish a non-invasive test to improve early detection of esophageal cancer that is based upon the unique signature of volatile organic compounds (VOCs) within exhaled breath and to analyze exhaled VOCs in response to therapeutic intervention in patients.
Awareness. Thanks to our wonderful community of supporters, we are bringing our Esophageal Cancer Awareness events across the country! This year, we were able to finally host our in-person events in Rhode Island and with the help of our Chapter Representatives, in Colorado as well. Awareness events also took place in New Jersey, Massachusetts, Minnesota, New York and Missouri. In 2022, we hosted another world-wide Virtual Esophageal Cancer Walk/Run event.
Over the years, we’ve also worked with supporters to host awareness events in Ohio, Arizona, Kentucky, Virginia, Maine, and Illinois, with more locations in the planning stages. These events have given rise to chapters in St. Louis, Missouri; Arvada, Colorado and Brooklyn, New York, in addition to our headquarters in Rhode Island. Stay tuned for more events and in more locations in 2023!
Our Brooklyn, NY Chapter Representative, Dara, continued the groundbreaking “Esophageal Cancer Survivor Series,” ongoing Facebook live video interviews with survivors of esophageal cancer. If you or someone you know is an esophageal cancer survivor and would like to share a story, please contact us.
Top Rated! Thanks to the help of our wonderful community of supporters who took the time to post a review, we were one of the first winners of a 2022 Top-Rated Award from GreatNonprofits! Read inspiring reviews and write one of your own: https://greatnonprofits.org/org/salgi-esophageal-cancer-research-foundation
Mission 2023. While all of these are remarkable accomplishments, esophageal cancer research remains largely underfunded, with researchers continuously reaching out to our charity. Awareness is still limited, as many people are unaware of the risk factors and symptoms of esophageal cancer. Doctors have also warned that the pandemic caused a significant decrease in cancer diagnoses, including esophageal cancer, which impacts could be seen for years to come. When it comes to esophageal cancer, as other cancers, earliest possible detection and treatments are crucial for survival!
You Can Help. Would you please consider making a year-end donation to help us continue to fuel this mission?
Don’t miss out on making your 2022 donation. Your support will make a lasting impact. All donations are 100% tax-deductible and can be made as a special gift, in honor of or in memory of a loved one. Please, click here to make your donation now.
If you have already made a year-end gift, please accept our sincere thanks and gratitude!
The Salgi Esophageal Cancer Research Foundation, a 501(c)(3) nonprofit located in Rhode Island, has opened its Grant Program for funding of esophageal cancer research for the third time since the charity first opened its doors in 2011.
Then in 2018, The Salgi Esophageal Cancer Research Foundation awarded principal investigator, Dr. Donald Low and Virginia Mason Medical Center, grant funding. Dr. George Hanna of St Mary’s Hospital (Imperial College London) is co-investigator. The research intends to establish a non-invasive test for the detection of esophageal cancer that is based upon the unique signature of volatile organic compounds (VOCs) within exhaled breath and to analyze exhaled VOCs in response to therapeutic intervention in patients. This research is currently underway.
With over a 733% increase in the past four decades, esophageal cancer is among the fastest growing and deadliest cancers in the United States and the western world. There are no current standard or routine screenings to detect esophageal cancer in its earlier stages. Current guidelines recommend referral for endoscopy “only in the setting of ‘red flag’ symptoms that are frequently associated with inoperable disease,” Dr. Low stated.
These ‘red flag’ symptoms, such as difficulty swallowing, chronic cough, and GERD, typically appear once the cancer has become advanced. This, in addition with other factors, leads to the current overall five-year survival rate of only 20.6%. Despite its rapid increase and poor prognosis, esophageal cancer receives very little awareness and research funding.
Despite its rapid increase and poor prognosis, many people are still unaware of esophageal cancer and research is critically underfunded. “We are honored to once again open our Grant Program and look forward to awarding esophageal cancer research funding in 2023.”
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
“The Dangerous Link Between Chronic Reflux and Esophageal Cancer.”
Each year, the week of Thanksgiving is also dedicated to bringing awareness to a growing disease which affects roughly 20% of Americans. That disease is Gastroesophageal Reflux Disease (GERD).
Also known as acid reflux disease, GERD is a condition of the digestive system, which has increased significantly in recent decades. GERD is also a primary risk factor for esophageal cancer, one of the fastest growing and deadliest cancers in the United States. Esophageal cancer, like GERD, has also increased significantly in past decades. In fact, incidence of esophageal cancer has risen over 733% in the past four decades and has only an overall five-year survival rate of approximately 19.9%.
The Salgi Esophageal Cancer Research Foundation, a nonprofit, which has funded two grants for esophageal cancer research (one in July, 2015 and another in November, 2018) and opened the Grant Program again in November 2022, is working once again to bring awareness of the dangerous link between GERD and esophageal cancer. While GERD has many symptoms, the most common symptom is heartburn.
Heartburn does not typically cause major concern, as billions of Americans experience it at some point in their lives. However, persistent heartburn, which occurs two or more times a week, should not be taken lightly, as it could be a symptom of the disease.
President of The Salgi Foundation, Linda Molfesi, said, “my father suffered from chronic heartburn for years and was never warned by doctors of the possible risks. We found out too late, once he started having difficulty swallowing, that his chronic reflux had led to esophageal cancer.” Molfesi continued, “My father passed away a little over a year after he was diagnosed and it was, and still is, devastating.”
Esophageal cancer, which, when caught in advanced stages, is very difficult to treat and has a poor survival rate. Esophageal cancer has few, if any, early symptoms. Symptoms such as difficulty swallowing, chronic cough or hoarseness, food getting stuck or choking while eating often occur once the cancer has spread and reaches an advanced stage. There are currently no routine or standard screenings to detect esophageal cancer in its earlier stages. The foundation is hoping to help change that, awarding $62,597 in November, 2018, to researchers at Virginia Mason Medical Center who are currently developing a breath test for detecting esophageal cancer earlier.
Molfesi encourages those who suffer from chronic reflux to be proactive about their health, stating “never ignore frequent heartburn or other symptoms and never rely on medications alone. Talk to your primary care doctor about all of your options, especially how you can get screened for any possible damage.”
The Salgi Esophageal Cancer Research Foundation: is a 501(c)(3) nonprofit whose mission is to raise awareness, encourage early detection and to fund research of esophageal cancer in hopes of a cure.™ The charity has hosted events in Rhode Island, Missouri, Colorado, Ohio, Kentucky, New York City, Massachusetts, Virginia, Maine, New Jersey and Illinois, with additional locations currently in the planning stages. These events gave rise to chapters in St. Louis, Missouri; Arvada, Colorado and Brooklyn, New York.
Learn the Facts About Esophageal Cancer:
No standard or routine screening to detect cancer in earlier stages
One of the fastest growing and deadliest cancers in the US and western world
Symptoms often arise once the cancer has spread
Research receives low government and/or private funding
In 2022, estimated 20,640 diagnoses and 16,410 deaths from the cancer.
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The Salgi Esophageal Cancer Research Foundation is preparing to open our Grant Program once again! Once the Grant Program is open, researchers will be invited to submit proposals for esophageal cancer research funding.
The more funding we raise, the more funding we can grant to worthy and potentially life-saving research. The Salgi Esophageal Cancer Research Foundation was established in November 2011. Since then, we have funded research in 2015 and 2018.
Due to the tumultuous past two years, we have been unable to fund research again…until now! Stay tuned as we continue to work to open the Grant Program!
Thank you to all our community of supporters who have tirelessly worked alongside us to achieve these goals…in hopes of a CURE™!
Learn the facts about esophageal cancer
-Esophageal cancer has increased over 733% in the past four decades and is considered the fastest growing cancer in the US and western world.
Brooklyn, NY 4th Annual Esophageal Cancer Awareness 5K Run/Walk took place on Saturday, September 17, 2022 at Marine Park in Brooklyn, NY.
Thank you to everyone who signed up, donated, and/or created a fundraising team!
Special thank you to our Chapter Representative, Dara for her hard work, enthusiasm and dedication to this mission in loving memory of her father, Joe M.
Colorado’s 5th Annual Esophageal Cancer Walk/Run took place on Saturday, September 17, 2022 at O’Kane Park in Lakewood, CO.
Thank you to everyone who signed up, donated, and/or created a fundraising team! Special thank you to our Chapter Representatives and Lead Event Coordinators: Joy, Monica and Lindsey.
In loving memory of Roy Ivan Parrish and all others who have been impacted by this horrific cancer.
Gastroesophageal Reflux Disease (GERD), a risk factor of esophageal cancer, is also known as acid reflux disease. GERD occurs when stomach acids flow backwards into the esophagus. The culprit? Your lower esophageal sphincter (LES). The LES is a ring of muscle that opens to allow food and drink to pass into the stomach from the mouth.
A normal functioning LES then closes to keep those contents inside the stomach to allow for digestion. When the LES is damaged, it becomes weak and relaxes, allowing stomach acids and contents to flow back up into the esophagus. This “reflux” symptom is known as heartburn.
While not all GERD sufferers experience this symptom (heartburn), people who do suffer from heartburn more than twice a week should speak with their doctor.
Overtime, the reflux of stomach acids damages the lining of the esophageal wall and can cause the cells to become abnormal and potentially lead to serious health problems including Barrett’s esophagus and/or esophageal cancer.
There are no standard or routine screenings to detect esophageal cancer in its earlier stages, when the tumors can be better treated. Unfortunately, symptoms such as difficulty swallowing and food getting stuck typically appear once the cancer has spread. When esophageal cancer is diagnosed at later stages, there is a poor survival rate, as treatment options are limited and mostly used to treat cancer symptoms, not towards curing the cancer. Stage IV has a survival rate of less than 6%. The earlier esophageal cancer is detected, the better chances for survival.
It is imperative that people speak to with their doctor about tests to screen for esophageal cancer. Remember, early detection saves lives! Feel free to share this information with your family and friends. We’ve included social media buttons below to make sharing simple.
Donations are what fuel awareness programs and research projects working to find a cure for esophageal cancer. All donations are tax-deductible and can be made online.
Click hereto make a one-time or recurring donation. Thank you in advance for joining us in this mission to save lives and find a cure!
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Posted by salgiblogs 
The Salgi Esophageal Cancer Research Foundation 